Literature DB >> 35755172

Botryoid connective tissue nevi: An uncommon presentation of hamartoma of the skin.

Emma Huard1, Margot Raynal1, Sylvie Fraitag2, Emilie Angot3, Solen Raymond4, Vivien Hebert1, Raphael Janela1.   

Abstract

Entities:  

Keywords:  CTN, connective tissue nevi; RMS, rhabdomyosarcoma; botryoid pattern; connective tissue nevi; rhabdomyosarcoma

Year:  2022        PMID: 35755172      PMCID: PMC9218140          DOI: 10.1016/j.jdcr.2022.05.020

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

Connective tissue nevi (CTN) are hamartomas of the skin, resulting from a malformation of the dermis, by increase or alteration of one or more components of the extracellular matrix. A first classification of CTN was established in 1980 by Uitto et al based on the type of component involved. Following the discovery of new patterns of CTN, McCuaig et al proposed a revisited classification in 2012. The incidence of CTN is unknown, and the disease is probably underdiagnosed. The diagnosis is often established in early childhood. Classically, CTN appear as firm, asymptomatic, flesh-colored or yellowish papules or nodules of the dermis. Sometimes, they may have a tumor-like appearance. CTN are most often found on the trunk and extremities. In the majority of the cases, lesions are solitary and localized, but disseminated lesions may be observed. CTN can be congenital or acquired, sporadic or inherited, and may also be part of a syndrome. There is a large variability in the clinical and histologic presentation of CTN. We describe a rare case of CTN with an unusual botryoid presentation.

Case report

We report the case of a 1-year-old child referred to the dermatology department for a congenital lesion of the left thigh, which had gradually increased. The lesion was clinically soft, papillomatous, not infiltrated, and asymptomatic (Fig 1). There was no other anomaly on clinical examination. In particular, neurologic examination was normal, and there was no associated deafness. Microcystic lymphatic malformation was initially suspected, and an ultrasound examination was performed, consistent with this diagnosis. However, the lesion subsequently increased in size (Fig 2) and was complicated by local infection. Magnetic resonance imaging revealed a lesion strictly localized in the skin. Surgical management was decided.
Fig 1

A soft and papillomatous lesion of the left thigh.

Fig 2

An increase in the size of the lesion during follow-up.

A soft and papillomatous lesion of the left thigh. An increase in the size of the lesion during follow-up. Histologic examination (Fig 3) revealed a malformation of the dermis, involving an increase in a contingent of small spindle cells; poorly differentiated, with a relatively regular nucleus, and of striated muscle origin (desmine+, myogenin+). This was associated with the presence of multiple small buds located in the dermis containing numerous vessels and with a botryoid pattern. Immunohistochemical analysis excluded sarcoma (PAX5−), hemopathies (CD3−, CD20−, and MPO−) and Kaposi disease (HHV8−). Because of the increase of striated muscle cells, and despite the negativity of the marker PAX5 in the immunohistochemical analysis, genetic analysis was carried out so as not to disregard a diagnosis of rhabdomyosarcoma (RMS). Molecular biology analysis did not reveal any genomic alteration, ruling out the hypothesis of a botryoid RMS. The final diagnosis retained was botryoid CTN because of the increase in a benign contingent of striated muscle with a botryoid pattern. The clinical course was favorable after resection without recurrence.
Fig 3

Skin biopsy. Multiple small buds were located in the dermis, with a botryoid pattern and containing numerous vessels. There was an association with small spindle cells of striated muscle differentiation. (A, and B, Hematoxylin-eosin stain; original magnification: A, ×2; B, ×40. C, Desmine+ stain. D, Myogenin+ stain. E, PAX5–stain. F, HHV8–stain.)

Skin biopsy. Multiple small buds were located in the dermis, with a botryoid pattern and containing numerous vessels. There was an association with small spindle cells of striated muscle differentiation. (A, and B, Hematoxylin-eosin stain; original magnification: A, ×2; B, ×40. C, Desmine+ stain. D, Myogenin+ stain. E, PAX5–stain. F, HHV8–stain.)

Discussion

CTN are benign tumors of the skin and include a large spectrum of different clinical and histologic presentations. Although the 3 main components usually found in CTN are collagen, elastin, and proteoglycans, other components can also be involved, including fibroblastic or cellular components. In our case, the histology of the lesion was surprising, because of the presence of a botryoid pattern, which, to our knowledge, has never been described before. This histologic presentation required the exclusion of the differential diagnosis of a botryoid RMS, which has a radically different prognosis and management. Indeed, RMS is the most common soft-tissue sarcoma in children and corresponds to a malignant tumor. It is frequently characterized by an asymptomatic mass, localized on the head, the genito-urinary tract, or the extremities. Nevertheless, symptoms may appear by compression of adjacent structures. There are several histologic subtypes, with the botryoid pattern being a rare variant of RMS. In cases of botryoid RMS, the clinical aspect may be a papillomatous lesion, usually localized on the mucous membranes. The major risk of this disease is the appearance of metastases, and the overall survival at 5 years is estimated at 70%; hence the need for a rapid diagnosis. However, in our case, the absence of genetic alteration allowed us to eliminate this hypothesis and to make the final diagnosis of botryoid CTN (Table I).
Table I

Characteristics of connective tissue nevi, botryoid-subtype connective tissue nevi, and rhabdomyosarcoma

CharacteristicsCTNBotryoid-subtype CTNRMS
EpidemiologyFrequency unknown, probably underestimatedEarly childhood (0-5 yrs)Type: sporadic lesions > inherited condition; acquired > congenitalUncommon presentationOne-year-old childSporadic lesionMost common type of soft-tissue sarcoma in children (6 cases/million inhabitants/y)Peak incidence: early childhood (2-6 yrs) and adolescence (10-18 yrs)Sporadic form > familial syndromes
HistologyIncrease or alteration of one or more components of the extracellular matrix of the dermisMain components: collagen, elastin, and proteoglycanRarely: fibroblastic or cellularIncrease in spindle cells of striated muscle origin (cellular component) in the dermisAssociation with multiple small buds, located in the dermis, and containing multiple vessels, with a botryoid patternIHC: desmine+, myogenin+, PAX5, CD3, CD20, MPOMolecular biology: absence of genomic alterationInfiltrate of malignant cells of striated muscle originMain histologic subtypes: embryonal > alveolar > spindle/sclerosing > pleomorphicBotryoid subtype: rare variant of embryonal typeIHC: desmine+, myogenin+/−, MyoD1+/−Molecular biology: genomic alterations
Clinical aspectsFirm and asymptomatic papules, flesh-colored or yellowishSites: trunk, extremitiesSolitary and localized lesions > multiple lesionsSoft and asymptomatic, flesh-colored lesion, with a grape-like appearanceLocalized on the thighSolitary lesionAsymptomatic mass or symptomatic by compression of adjacent structuresSites: head and neck region, genito-urinary tract, extremitiesRMS botryoid: grape-like appearance, usually localized in mucous membranes
Clinical courseBenign course, usually without complicationTreatment: no consensus, often surgery without recurrenceRapid extension in sizeAbsence of recurrence after surgeryRisk of metastasesTreatment: association of chemotherapy, surgery, and radiotherapyOverall survival at 5 years: 70%

CTN, Connective tissue nevi; IHC, immunohistochemistry; RMS, rhabdomyosarcoma.

Characteristics of connective tissue nevi, botryoid-subtype connective tissue nevi, and rhabdomyosarcoma CTN, Connective tissue nevi; IHC, immunohistochemistry; RMS, rhabdomyosarcoma. Even if it is a benign malformation, a diagnosis of CTN must lead to rigorous medical history taking and clinical examination, as these tumors may be indicative of a syndromic disease, such as Buschke-Ollendorff syndrome, proteus syndrome, tuberous sclerosis complex, or multiple endocrine neoplasia type 1. The clinical examination should include a search for symptoms, such as neurologic disorders, deafness, or other associated skin lesions, as the presence of one of these signs may guide the diagnosis toward a syndromic form of CTN. There is no consensus regarding treatment. Treatment is selected after considering CTN subtype, the number and location of the lesions, and the age of the patient. Surgery is the most frequent treatment modality reported, as in our case, because the lesion was complicated by an infection and developing rapidly. Alternative therapeutic options for usual subtypes are laser, intralesional injection of corticosteroid, or therapeutic abstention. In conclusion, we report a rare case of botryoid CTN, which highlights the variability of presentation and the difficulty of making the diagnosis. The final diagnosis was based on histologic findings. In our case, complete surgical removal was required because of the rapid development and the initial diagnostic doubt.

Conflicts of interest

None disclosed.
  10 in total

1.  Connective tissue nevi: an entity revisited.

Authors:  Anne Saussine; Karine Marrou; Phillippe Delanoé; Nathalie Bodak; Dominique Hamel; Arnaud Picard; Bruno Sassolas; Yves de Prost; Martine Lemerrer; Sylvie Fraitag; Christine Bodemer
Journal:  J Am Acad Dermatol       Date:  2011-10-19       Impact factor: 11.527

Review 2.  Connective Tissue Nevi: A Review of the Literature.

Authors:  Harleen Arora; Leyre Falto-Aizpurua; Andrea Cortés-Fernandez; Sonal Choudhary; Paolo Romanelli
Journal:  Am J Dermatopathol       Date:  2017-05       Impact factor: 1.533

3.  Connective tissue nevi in children: institutional experience and review.

Authors:  Catherine C McCuaig; Caridad Vera; Victor Kokta; Danielle Marcoux; Afshin Hatami; Thusanth Thuraisingam; Dominique Marton; Geneviève Fortier-Riberdy; Julie Powell
Journal:  J Am Acad Dermatol       Date:  2012-06-26       Impact factor: 11.527

Review 4.  Three cases of eruptive collagenoma and a literature review, 1970-2012.

Authors:  Min Xiao; Liu Yang; Liyun Dong; Yujue Wang; Xiaoyan Sun; Juan Tao
Journal:  Eur J Dermatol       Date:  2014 May-Jun       Impact factor: 3.328

Review 5.  What is new in rhabdomyosarcoma management in children?

Authors:  Yasmin Gosiengfiao; Jennifer Reichek; David Walterhouse
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

6.  Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type.

Authors:  J Uitto; D J Santa Cruz; A Z Eisen
Journal:  J Am Acad Dermatol       Date:  1980-11       Impact factor: 11.527

7.  Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases.

Authors:  Sébastien de Feraudy; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 8.  Rhabdomyosarcoma: an overview and nursing considerations.

Authors:  Úna Kerin; Colleen Wolohan; Karen Cooke
Journal:  Br J Nurs       Date:  2018-03-22

Review 9.  Rhabdomyosarcoma.

Authors:  Roshni Dasgupta; Jörg Fuchs; David Rodeberg
Journal:  Semin Pediatr Surg       Date:  2016-09-20       Impact factor: 2.754

10.  Botryoid Rhabdomyosarcoma of the Conjunctiva in a Young Boy.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  Middle East Afr J Ophthalmol       Date:  2019 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.